Belimumab ameliorates symptoms and disease activity in patients with dermatomyositis and juvenile dermatomyositis refractory to standard therapy: A retrospective observational study

Yu Liu(Central South University), Hai Long(Central South University), Xiaoyan Li(Nanjing Agricultural University), Xiqiang Dang(Second Xiangya Hospital of Central South University), Yongzhen Li(Xihua University), Tian Shen(Columbia University Irving Medical Center), Qing Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Huiming Zhang(Eastern Institute of Technology), Shuangyan Luo(Central South University)
Journal of the American Academy of Dermatology
May 1, 2024
Cited by 12


Related Papers